Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder

被引：0
|
作者：
Aimee M. Hunter
Ian A. Cook
Molly Tartter
Simi K. Sharma
Gregory D. Disse
Andrew F. Leuchter
机构：
[1] University of California Los Angeles,Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA
[2] University of California Los Angeles,Neuromodulation Division, Semel Institute for Neuroscience and Human Behavior at UCLA
[3] University of California Los Angeles,Department of Bioengineering
[4] University of California Los Angeles,Department of Psychology
来源：
Psychopharmacology | 2015年 / 232卷
关键词：
Antidepressant treatment history; Tachyphylaxis; Tolerance; Placebo response; Antidepressant medication; Randomized clinical trial; Treatment-resistant depression; Expectations;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3833 / 3840
页数：7
相关论文
共 50 条
  • [1] Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder
    Hunter, Aimee M.
    Cook, Ian A.
    Tartter, Molly
    Sharma, Simi K.
    Disse, Gregory D.
    Leuchter, Andrew F.
    PSYCHOPHARMACOLOGY, 2015, 232 (20) : 3833 - 3840
  • [2] Placebo-controlled trial of agomelatine in the treatment of major depressive disorder
    Kennedy, SH
    Emsley, R
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 (02) : 93 - 100
  • [3] A placebo-controlled trial of escitalopram and sertraline in the treatment of major depressive disorder
    Alexopoulos, GS
    Gordon, J
    Zhang, DZ
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S87 - S87
  • [4] Randomized, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder
    DeMartinis, N.
    Yeung, P. P.
    Entsuah, R.
    Manley, A. L.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S233 - S234
  • [5] Replication of Scopolamine's Antidepressant Efficacy in Major Depressive Disorder: A Randomized, Placebo-Controlled Clinical Trial
    Drevets, Wayne C.
    Furey, Maura L.
    BIOLOGICAL PSYCHIATRY, 2010, 67 (05) : 432 - 438
  • [6] A Randomized, Placebo-Controlled Adjunctive Trial of Riluzole in Treatment-Resistant Major Depressive Disorder
    Mathew, Sanjay
    Fava, Maurizio
    Guerguieva, Ralitza
    Sanacora, Gerard
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S161 - S162
  • [7] A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder
    Lépine, JP
    Caillard, V
    Bisserbe, JC
    Troy, S
    Hotton, JM
    Boyer, P
    AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (05): : 836 - 842
  • [8] Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo-Controlled Phase 3 Trial
    Clayton, Anita H.
    Lasser, Robert
    Parikh, Sagar, V
    Iosifescu, Dan, V
    Jung, Jungah
    Kotecha, Mona
    Forrestal, Fiona
    Jonas, Jeffrey
    Kanes, Stephen J.
    Doherty, James
    AMERICAN JOURNAL OF PSYCHIATRY, 2023, 180 (09): : 676 - 684
  • [9] An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder
    Berard, R
    Fong, R
    Carpenter, DJ
    Thomason, C
    Wilkinson, C
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (1-2) : 59 - 75
  • [10] Bright Light Treatment in Elderly Patients With Nonseasonal Major Depressive Disorder A Randomized Placebo-Controlled Trial
    Lieverse, Ritsaert
    van Someren, Eus J. W.
    Nielen, Marjan M. A.
    Uitdehaag, Bernard M. J.
    Smit, Jan H.
    Hoogendijk, Witte J. G.
    ARCHIVES OF GENERAL PSYCHIATRY, 2011, 68 (01) : 61 - 70
12345